Baker Bros. Advisors LP
- SEC CIK
- 0001263508
- Latest filing
- Aug 14, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 122
- +2 vs. Q2 2021
- Portfolio value
- $22.8B
- +$1.74M (0.0%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SGENSeagen Inc. | COM | 47,288,259 | $8.03B | 35.3% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 11,668,897 | $4.24B | 18.6% | 00.0% | Unchanged | History |
| INCYIncyte Corp | COM | 32,022,125 | $2.20B | 9.7% | +3930.0% | Added | History |
| KODKodiak Sciences Inc. | COM | 14,681,304 | $1.41B | 6.2% | +543,423+3.8% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 4,541,604 | $723.9M | 3.2% | +1,001,334+28.3% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 41,910,704 | $696.1M | 3.1% | 00.0% | Unchanged | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 7,620,494 | $589.0M | 2.6% | +31,200+0.4% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 1,119,557 | $338.1M | 1.5% | 00.0% | Unchanged | History |
| PRLDPrelude Therapeutics Inc | COM | 10,123,824 | $316.4M | 1.4% | 00.0% | Unchanged | History |
| NVTAInvitae Corp | COM | 9,873,488 | $280.7M | 1.2% | −375,087−3.7% | Reduced | History |
| MRTXMirati Therapeutics, Inc. | COM | 1,409,784 | $249.4M | 1.1% | 00.0% | Unchanged | History |
| ABCLAbCellera Biologics Inc. | COM | 10,450,180 | $209.4M | 0.9% | 00.0% | Unchanged | History |
| IGMSIGM Biosciences, Inc. | COM | 3,156,102 | $207.5M | 0.9% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 12,710,818 | $182.7M | 0.8% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 2,384,742 | $140.1M | 0.6% | +425,531+21.7% | Added | History |
| PACBPacific Biosciences of California, Inc. | COM | 5,444,963 | $139.1M | 0.6% | +2,242,991+70.1% | Added | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 1,499,213 | $119.6M | 0.5% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 2,364,003 | $119.5M | 0.5% | +699,469+42.0% | Added | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 21,856,032 | $111.5M | 0.5% | −4,597,390−17.4% | Reduced | History |
| IMCRImmunocore Holdings plc | ADS | 2,520,730 | $93.4M | 0.4% | 00.0% | Unchanged | History |
| HRTXHeron Therapeutics, Inc. | COM | 8,131,678 | $86.9M | 0.4% | 00.0% | Unchanged | History |
| CERSCerus Corp | COM | 13,713,195 | $83.5M | 0.4% | 00.0% | Unchanged | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 3,217,441 | $82.0M | 0.4% | 00.0% | Unchanged | History |
| ALLKAllakos Inc. | COM | 703,050 | $74.4M | 0.3% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 2,454,082 | $73.5M | 0.3% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 14,614,264 | $71.6M | 0.3% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM | 3,893,700 | $69.6M | 0.3% | 00.0% | Unchanged | History |
| VERVVerve Therapeutics, Inc. | COM | 1,416,530 | $66.6M | 0.3% | 00.0% | Unchanged | History |
| VSTMVerastem, Inc. | COM | 21,491,630 | $66.2M | 0.3% | 00.0% | Unchanged | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 599,110 | $65.6M | 0.3% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 676,975 | $64.9M | 0.3% | 00.0% | Unchanged | History |
| INSMINSMED Inc | COM PAR $.01 | 2,156,001 | $59.4M | 0.3% | 00.0% | Unchanged | History |
| IMTXImmatics N.V. | SHS | 4,423,731 | $57.5M | 0.3% | +140,793+3.3% | Added | History |
| Apellis Pharmaceuticals, Inc.03753UAB2 | NOTE 3.500% 9/1 | – | $57.3M | 0.3% | – | – | – |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 9,830,877 | $50.8M | 0.2% | 00.0% | Unchanged | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 3,863,239 | $50.5M | 0.2% | 00.0% | Unchanged | History |
| ZYMEZymeworks Inc. | COM | 1,708,472 | $49.6M | 0.2% | 00.0% | Unchanged | History |
| TVTXTravere Therapeutics, Inc. | COM | 2,039,772 | $49.5M | 0.2% | +1,852,857+991.3% | Added | History |
| BLUEbluebird bio, Inc. | COM | 2,499,715 | $47.8M | 0.2% | +2,272,727+1,001.3% | Added | History |
| TLISTalis Biomedical Corp | COM | 7,574,835 | $47.3M | 0.2% | 00.0% | Unchanged | History |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 2,024,876 | $47.0M | 0.2% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 2,037,469 | $44.8M | 0.2% | 00.0% | Unchanged | History |
| INSMED Inc457669AB5 | NOTE 0.750% 6/0 | – | $43.8M | 0.2% | – | – | – |
| Sarepta Therapeutics, Inc.803607AB6 | DBCV 1.500%11/1 | – | $43.2M | 0.2% | – | – | – |
| RAREUltragenyx Pharmaceutical Inc. | COM | 444,444 | $40.1M | 0.2% | 00.0% | Unchanged | History |
| ALKSAlkermes plc. | SHS | 1,228,170 | $37.9M | 0.2% | 00.0% | Unchanged | History |
| FLGTFulgent Genetics, Inc. | COM | 401,016 | $36.1M | 0.2% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM | 1,652,171 | $34.7M | 0.2% | +223,600+15.7% | Added | History |
| ALGSAligos Therapeutics, Inc. | COM | 2,076,400 | $32.2M | 0.1% | +466,400+29.0% | Added | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 2,799,577 | $31.9M | 0.1% | 00.0% | Unchanged | History |
| KRYSKrystal Biotech, Inc. | COM | 607,735 | $31.7M | 0.1% | 00.0% | Unchanged | History |
| Tricida, Inc.89610FAB7 | NOTE 3.500% 5/1 | – | $31.4M | 0.1% | – | – | – |
| NGNENeurogene Inc. | COM | 3,821,740 | $27.6M | 0.1% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM | 3,410,106 | $27.1M | 0.1% | 00.0% | Unchanged | History |
| CYVNYOpthea Ltd | SPONSORED ADS | 3,382,797 | $27.1M | 0.1% | −29,265−0.9% | Reduced | History |
| BCABBioAtla, Inc. | COM | 825,000 | $24.3M | 0.1% | 00.0% | Unchanged | History |
| KDNYChinook Therapeutics, Inc. | COM | 1,903,069 | $24.3M | 0.1% | +822,676+76.1% | Added | History |
| NVAXNovavax Inc | COM NEW | 108,756 | $22.5M | 0.1% | −35,000−24.3% | Reduced | History |
| RETAReata Pharmaceuticals Inc | CL A | 223,976 | $22.5M | 0.1% | 00.0% | Unchanged | History |
| BCELAtreca, Inc. | CL A COM | 3,532,760 | $22.0M | 0.1% | 00.0% | Unchanged | History |
| DSGNDesign Therapeutics, Inc. | COM | 1,436,636 | $21.1M | 0.1% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,591,366 | $20.2M | 0.1% | 00.0% | Unchanged | – |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 920,656 | $19.4M | 0.1% | 00.0% | Unchanged | History |
| DICEDICE Therapeutics, Inc. | COM | 588,235 | $19.3M | 0.1% | +588,235 | New | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,127,273 | $18.8M | 0.1% | +727,273+181.8% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 539,057 | $17.8M | 0.1% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 2,500,000 | $17.7M | 0.1% | +2,500,000 | New | History |
| OTICOtonomy, Inc. | COM | 7,694,038 | $14.8M | 0.1% | +471,564+6.5% | Added | History |
| CYTCyteir Therapeutics, Inc. | COM | 812,640 | $14.3M | 0.1% | 00.0% | Unchanged | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 647,313 | $12.9M | 0.1% | 00.0% | Unchanged | History |
| ALBOAlbireo Pharma, Inc. | COM | 412,466 | $12.9M | 0.1% | 00.0% | Unchanged | History |
| Invitae Corp46185LAB9 | NOTE 2.000% 9/0 | – | $12.6M | 0.1% | – | – | – |
| ALTAltimmune, Inc. | COM NEW | 1,072,038 | $12.1M | 0.1% | 00.0% | Unchanged | History |
| TCRXTScan Therapeutics, Inc. | COM | 1,425,000 | $11.9M | 0.1% | +1,425,000 | New | History |
| ANABAnaptysbio, Inc | COM | 427,179 | $11.6M | 0.1% | 00.0% | Unchanged | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 520,523 | $11.5M | 0.1% | −599,439−53.5% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 751,639 | $11.5M | 0.1% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 750,000 | $9.70M | <0.1% | +750,000 | New | History |
| MGNXMacrogenics Inc | COM | 442,579 | $9.27M | <0.1% | +241,900+120.5% | Added | History |
| KRTXKaruna Therapeutics, Inc. | COM | 69,966 | $8.56M | <0.1% | 00.0% | Unchanged | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 500,000 | $8.30M | <0.1% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 662,063 | $8.05M | <0.1% | +25,700+4.0% | Added | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 2,170,464 | $7.92M | <0.1% | 00.0% | Unchanged | History |
| LONALeonaBio, Inc. | COM | 806,367 | $7.56M | <0.1% | 00.0% | Unchanged | History |
| Genetron Hldgs Ltd37186H100 | ADS | 455,306 | $6.31M | <0.1% | 00.0% | Unchanged | – |
| BMEABiomea Fusion, Inc. | COM | 524,617 | $6.28M | <0.1% | +230,500+78.4% | Added | History |
| Amryt Pharma PLC03217L106 | SPONSORED ADS | 518,380 | $6.24M | <0.1% | +518,380 | New | – |
| NGMNGM Biopharmaceuticals Inc | COM | 291,801 | $6.13M | <0.1% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 222,222 | $6.11M | <0.1% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 304,158 | $5.70M | <0.1% | +304,158 | New | History |
| ATYRaTYR PHARMA INC | COM NEW | 625,000 | $5.67M | <0.1% | +625,000 | New | History |
| ALECAlector, Inc. | COM | 239,228 | $5.46M | <0.1% | 00.0% | Unchanged | History |
| RLMDRelmada Therapeutics, Inc. | COM | 200,996 | $5.27M | <0.1% | +124,396+162.4% | Added | History |
| ChemoCentryx, Inc.16383L106 | COM | 301,195 | $5.15M | <0.1% | +301,195 | New | – |
| TCDATricida, Inc. | COM | 1,037,432 | $4.81M | <0.1% | +308,132+42.3% | Added | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 123,600 | $4.74M | <0.1% | 00.0% | Unchanged | History |
| Biomarin Pharmaceutical Inc09061GAH4 | NOTE 0.599% 8/0 | – | $4.61M | <0.1% | – | – | – |
| REPLReplimune Group, Inc. | COM | 153,512 | $4.55M | <0.1% | 00.0% | Unchanged | History |
| DNLIDenali Therapeutics Inc. | COM | 88,738 | $4.48M | <0.1% | 00.0% | Unchanged | History |
| NEXINexImmune, Inc. | COM | 294,117 | $4.45M | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2021 (10)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 2,271,917 | $143.6M | 0.6% | History |
| ADCTADC Therapeutics SA | SHS | 1,418,107 | $34.5M | 0.2% | History |
| PTGXProtagonist Therapeutics, Inc | COM | 455,276 | $20.4M | 0.1% | History |
| ISEEIVERIC bio, Inc. | COM | 1,406,037 | $8.87M | <0.1% | History |
| ASMBAssembly Biosciences, Inc. | COM | 2,108,621 | $8.18M | <0.1% | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 238,095 | $7.36M | <0.1% | History |
| Chiasma, Inc16706W102 | COM | 1,420,740 | $6.72M | <0.1% | – |
| ORTXOrchard Therapeutics plc | ADS | 1,192,003 | $5.23M | <0.1% | History |
| KRROKorro Bio, Inc. | COM | 55,555 | $553.0K | <0.1% | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 65,497 | $357.0K | <0.1% | History |